Get the Stockscreener App
4.34
8.77%
0.35
After Hours:
4.29
-0.05
-1.15%
Zura Bio Ltd stock is traded at $4.34, with a volume of 1.41M.
It is up +8.77% in the last 24 hours and up +96.38% over the past month.
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
See More
Previous Close:
$3.99
Open:
$3.98
24h Volume:
1.41M
Relative Volume:
0.86
Market Cap:
$282.18M
Revenue:
-
Net Income/Loss:
$-60.36M
P/E Ratio:
-0.9877
EPS:
-4.394
Net Cash Flow:
$-15.05M
1W Performance:
+7.43%
1M Performance:
+96.38%
6M Performance:
+284.07%
1Y Performance:
+3.09%
1-Day Range:
$3.9769
$4.36
1-Week Range:
$3.5701
$4.36
52-Week Range:
$0.97
$5.07
Zura Bio Ltd Stock (ZURA) Company Profile
Name
Zura Bio Ltd
Sector
Industry
Phone
858-247-0520
Address
4225 EXECUTIVE SQUARE, LA JOLLA
Compare ZURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZURA
Zura Bio Ltd
|
4.34 | 259.42M | 0 | -60.36M | -15.05M | -4.394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Zura Bio Ltd Stock (ZURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-24 | Initiated | Leerink Partners | Outperform |
| Sep-05-24 | Initiated | H.C. Wainwright | Neutral |
| May-03-24 | Initiated | Piper Sandler | Overweight |
| Oct-10-23 | Initiated | Ladenburg Thalmann | Buy |
| Aug-25-23 | Initiated | Oppenheimer | Outperform |
| Jun-22-23 | Initiated | Guggenheim | Buy |
| Jun-14-23 | Initiated | Chardan Capital Markets | Buy |
| May-24-23 | Initiated | Raymond James | Strong Buy |
View All
Zura Bio Ltd Stock (ZURA) Latest News
Zura's Make-or-Break Year Ahead: Will TibuSHIELD And TibuSURE Trials Deliver Or Disappoint? - RTTNews
Is Zura Bio Limited stock overvalued by current metrics2025 Market Outlook & Capital Efficient Trade Techniques - newser.com
Does Zura Bio Limited show high probability of rebound2025 Winners & Losers & High Accuracy Investment Entry Signals - newser.com
Will Zura Bio Limited (94E) stock justify high valuation2025 Market Sentiment & Safe Entry Trade Reports - newser.com
Does Zura Bio's (ZURA) Severance Plan Reflect Management's Priorities Amid Cash Burn Pressures? - simplywall.st
Is Zura Bio’s (ZURA) Executive Severance Plan Hinting at Leadership Stability or Looming Funding Shifts? - Yahoo Finance
Top chart patterns to watch in Zura Bio LimitedMarket Rally & Advanced Technical Signal Analysis - newser.com
Is Zura Bio Limited stock a defensive play in 2025Weekly Trade Review & AI Forecast Swing Trade Picks - newser.com
What Price to Sales Ratio Tells Us About Voltas LimitedFlag and Pennant Patterns & Grow Smarter With Pro-Level Research - earlytimes.in
How to interpret RSI for Zura Bio Limited stock2025 AllTime Highs & Verified Momentum Stock Alerts - newser.com
Will Zura Bio Limited stock remain a Wall Street favoriteMarket Trend Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Quantitative breakdown of Zura Bio Limited recent moveMarket Activity Summary & Technical Entry and Exit Alerts - newser.com
Zura Bio Implements Executive Severance Benefit Plan - TipRanks
Best Biotech Stocks To ConsiderSeptember 30th - MarketBeat
Goldman Sachs Group Inc. Has $159,000 Stake in Zura Bio Limited $ZURA - Defense World
Morning Market Movers: SPRC, VALN, NBY, And Other Gainers & Losers - RTTNews
Chardan Capital Reiterates Buy Rating for Zura Bio (NASDAQ:ZURA) - MarketBeat
Is Zura Bio Limited (94E) stock bottoming after sell offJuly 2025 Snapshot & Target Return Focused Picks - newser.com
How to read the order book for Zura Bio LimitedQuarterly Performance Summary & Risk Controlled Stock Pick Alerts - newser.com
Smart tools for monitoring Zura Bio Limited’s price actionSwing Trade & Advanced Technical Analysis Signals - newser.com
Will Zura Bio Limited (94E) stock profit from AI boom2025 AllTime Highs & Daily Chart Pattern Signals - newser.com
Is Zura Bio Limited (94E) stock expanding market penetrationJuly 2025 Trends & Safe Capital Growth Plans - newser.com
How analysts rate Zura Bio Limited stock todayWeekly Profit Report & Verified Stock Trade Ideas - newser.com
Tools to monitor Zura Bio Limited recovery probabilityGap Up & Free Fast Entry Momentum Trade Alerts - newser.com
Is Zura Bio Limited (94E) stock a buy during volatile marketsPortfolio Gains Report & Long Hold Capital Preservation Plans - newser.com
Is Zura Bio Limited a good long term investmentBull Market Opportunities & Affordable Growth Investments - earlytimes.in
September 2025's Promising Penny Stocks Revealed - simplywall.st
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Will Zura Bio Limited stock outperform Dow Jones indexMarket Growth Report & Real-Time Volume Analysis - newser.com
Morning Market Movers: MRUS, PSTV, MLTX See Big Swings - RTTNews
Morning Market Movers: JFB, MLTX, MTEK, LRMR, MRUS See Big Swings - RTTNews
Zura Bio Ltd Stock (ZURA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.05%
4.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):